snapIoT has announced a successful integration of its mClinical platform, snapClinical, with ActiGraph’s CentrePoint System. This integration aims to give Sponsors and CROs improved power in data collection and insights for clinical trials.
ActiGraph’s medical-grade wearables and cloud-based data management platform provide a modern solution for collecting and delivering objective data points in real-time. These validated measurements provide insight into activity intensity, steps, energy expenditure, sleep time, and sleep efficiency. snapIoT’s mClinical platform delivers patient-centric mobile solutions to facilitate the collection of surveys and ePROs (electronic Patient Reported Outcomes) as well as monitor the daily operations of decentralized clinical trials. The COVID-19 crisis has made clear the need to leverage digital technologies to sustain clinical trials and protect the health of patients when normal trial operations are interrupted. The combination of digital patient monitoringalong with smart sensors provides safe methods to continue data collection via virtual outlets.
The data collected from ActiGraph’s wearables uploads to the Cloud where snapClinical can securely retrieve and store the data. With different types of measurements being collected through the sensors, snapIoT makes visualizing data simple by creating graphs that have the flexibility to overlay data points. snapClinical also allows users to easily compare these data points with other types of collected measurements, such as surveys and diaries. Sponsors and CROs can get insight into patients and ensure that they are engaged and compliant with the study protocol.
With the technology of snapIoT and ActiGraph, the integration between the two companies was accomplished in less than a week. The connectivity also makes it easy for newly validated algorithms to be implemented into the system as updates or other requirements are added. The integration provides simplistic efficiencies as the sensors are implemented directly into the snapClinical workflow engine. The power of snapIoT’s workflow engine ensures that the integration can be quickly deployed into new study protocols with minimal effort.
“We continue to drive more wearable and sensor integrations into our snapClinical platform in record timelines to fully support decentralized clinical trials. Our partnership with ActiGraph brings an industry integration to Sponsors and CROs offering a greater ability to quickly deliver a patient-centric experience,” said Isaac Eteminan, CEO of snapIoT.
“We were very impressed with snapIoT’s ability to quickly develop a platform integration to address our mutual customers’ requirements. As digital endpoints have become more prevalent, we know that providing contextual insights into patient behavior in tandem with objective sensor data is crucial in establishing the baseline for our pharma clients to make definitive regulatory claims. We’re excited about future opportunities with snapIoT, and this integration is a great start,” said Jeremy Wyatt, President & COO of ActiGraph.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.